The President & COO of Stryker Corporation (SYK) is Selling Shares


Today, the President & COO of Stryker Corporation (SYK), Timothy Scannell, sold shares of SYK for $922.4K.

Following Timothy Scannell’s last SYK Sell transaction on May 17, 2019, the stock climbed by 14.0%.

See today’s analyst top recommended stocks >>

Based on Stryker Corporation’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $3.52 billion and quarterly net profit of $412 million. In comparison, last year the company earned revenue of $3.24 billion and had a net profit of $443 million. SYK’s market cap is $74.08B and the company has a P/E ratio of 21.39. Currently, Stryker Corporation has an average volume of 255.9K.

Based on 12 analyst ratings, the analyst consensus is Strong Buy with an average price target of $205.09, reflecting a 3.5% upside.

The insider sentiment on Stryker Corporation has been negative according to 59 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts